The Case for Adolescent HIV Vaccination in South Africa

  title={The Case for Adolescent HIV Vaccination in South Africa},
  author={Nishila Moodley and Glenda Gray and Melanie Y. Bertram},
Despite comprising 0.7% of the world population, South Africa is home to 18% of the global human immunodeficiency virus (HIV) prevalence. Unyielding HIV subepidemics among adolescents threaten national attempts to curtail the disease burden. Should an HIV vaccine become available, establishing its point of entry into the health system becomes a priority. This study assesses the impact of school-based HIV vaccination and explores how variations in vaccine characteristics affect cost… CONTINUE READING